Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Weissleder

Showing results (51-60 of 196) with videos related to

Pageof 20
Sort By:
Radiology|February 15, 2000
Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent modelA Moore, E Marecos, A Bogdanov, et al.
Invasion & Metastasis|January 21, 2000
A model system to quantitate tumor burden in locoregional lymph nodes during cancer spreadA Moore, N Sergeyev, S Bredow, et al.
Cancer Research|December 16, 2000
Tyrosinase mutants are capable of prodrug activation in transfected nonmelanotic cellsM Simonova, A Wall, R Weissleder, et al.
Bioconjugate Chemistry|March 17, 1999
High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugatesL Josephson, C H Tung, A Moore, et al.
Radiology|February 1, 1996
Macromolecular intravenous contrast agent for MR lymphography: characterization and efficacy studiesL Harika, R Weissleder, K Poss, et al.
Cancer Research|September 15, 2000
In vivo imaging of proteolytic enzyme activity using a novel molecular reporterC H Tung, U Mahmood, S Bredow, et al.
Nature Biotechnology|April 20, 1999
In vivo imaging of tumors with protease-activated near-infrared fluorescent probesR Weissleder, C H Tung, U Mahmood, et al.
Radiology|February 1, 1992
Receptor-directed contrast agents for MR imaging: preclinical evaluation with affinity assaysP Reimer, R Weissleder, J Wittenberg, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 17, 1999
Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agentW S Enochs, G Harsh, F Hochberg, et al.
Gene Therapy|May 14, 2004
Molecular imaging of gene therapy for cancerK Shah, A Jacobs, X O Breakefield, et al.
Pageof 20

Showing results (51-60 of 196) with videos related to

Sort By:
Pageof 20
Radiology|February 15, 2000
Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent modelA Moore, E Marecos, A Bogdanov, et al.
Invasion & Metastasis|January 21, 2000
A model system to quantitate tumor burden in locoregional lymph nodes during cancer spreadA Moore, N Sergeyev, S Bredow, et al.
Cancer Research|December 16, 2000
Tyrosinase mutants are capable of prodrug activation in transfected nonmelanotic cellsM Simonova, A Wall, R Weissleder, et al.
Bioconjugate Chemistry|March 17, 1999
High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugatesL Josephson, C H Tung, A Moore, et al.
Radiology|February 1, 1996
Macromolecular intravenous contrast agent for MR lymphography: characterization and efficacy studiesL Harika, R Weissleder, K Poss, et al.
Cancer Research|September 15, 2000
In vivo imaging of proteolytic enzyme activity using a novel molecular reporterC H Tung, U Mahmood, S Bredow, et al.
Nature Biotechnology|April 20, 1999
In vivo imaging of tumors with protease-activated near-infrared fluorescent probesR Weissleder, C H Tung, U Mahmood, et al.
Radiology|February 1, 1992
Receptor-directed contrast agents for MR imaging: preclinical evaluation with affinity assaysP Reimer, R Weissleder, J Wittenberg, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 17, 1999
Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agentW S Enochs, G Harsh, F Hochberg, et al.
Gene Therapy|May 14, 2004
Molecular imaging of gene therapy for cancerK Shah, A Jacobs, X O Breakefield, et al.
Pageof 20